Lack of sphingomyelin synthase 2 reduces cerebral ischemia/reperfusion injury by inhibiting microglial inflammation in mice

Yang,Yu; Hu,Fengxian; Yang,Guifeng; Meng,Qingmei

doi:10.3892/etm.2020.9371

Lack of sphingomyelin synthase 2 reduces cerebral ischemia/reperfusion injury by inhibiting microglial inflammation in mice

Authors:
- Yu Yang
- Fengxian Hu
- Guifeng Yang
- Qingmei Meng
View Affiliations

Affiliations: Department of Radiology, The Third People's Hospital of Qingdao, Qingdao, Shandong 266041, P.R. China
Published online on: October 22, 2020 https://doi.org/10.3892/etm.2020.9371
Article Number: 241
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recanalization of blood flow after ischemia can lead to ischemia/reperfusion injury, and inflammation plays an important role in the mechanisms behind cerebral ischemia/reperfusion injury. Sphingomyelin synthase 2 (SMS2) deficiency reduces inflammation; however, the effect and mechanism of action of SMS2 on the inflammatory response after cerebral ischemia/reperfusion injury are still unclear. Wild‑type (WT) and SMS2 knockout C57BL/6 mice were used to establish a model of cerebral ischemia/reperfusion. The neurological deficit score was evaluated with Longa's method, and infarct volume was evaluated by magnetic resonance imaging and 2,3,5‑triphenyltetrazolium chloride staining. Neurological deficit and infarct volume were used to evaluate the degree of cerebral ischemia/reperfusion injury in mice. Western blotting, reverse transcription‑quantitative PCR and immunofluorescence were used to detect the expression profiles. The neurological deficit score of SMS2^‑/‑ mice was significantly lower than that of WT mice at 72 h after cerebral ischemia/reperfusion injury (P=0.027), but not significantly different at 24 h (P=0.064). Compared with WT mice at 24 and 72 h after cerebral ischemia/reperfusion, the infarct volume of SMS2^‑/‑ mice was decreased, the expression of pro‑inflammatory cytokines galectin 3 and interleukin‑1β were decreased, the activation of microglia was decreased, and the nuclear translocation of NF‑κB p65 was decreased, but the expression of the anti‑inflammatory factor arginase 1 was increased. Lack of SMS2 in mice can help to reduce the inflammatory reaction by inhibiting the activation of NF‑κB signaling pathway, further attenuating cerebral ischemia/reperfusion injury in mice.

View Figures

View References

1	Lapi D and Colantuoni A: Remodeling of cerebral microcirculation after ischemia-reperfusion. J Vasc Res. 52:22–31. 2015.PubMed/NCBI View Article : Google Scholar
2	Jean WC, Spellman SR, Nussbaum ES and Low WC: Reperfusion injury after focal cerebral ischemia: The role of inflammation and the therapeutic horizon. Neurosurgery. 43:1382–1396. 1998.PubMed/NCBI View Article : Google Scholar
3	Wang YS, Li YX, Zhao P, Wang HB, Zhou R, Hao YJ, Wang J, Wang SJ, Du J, Ma LJ, et al: Anti-inflammation effects of oxysophoridine on cerebral ischemia-reperfusion injury in mice. Inflammation. 38:2259–2268. 2015.PubMed/NCBI View Article : Google Scholar
4	Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X and Zhang S: Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia/reperfusion. J Neurochem. 105:1737–1745. 2008.PubMed/NCBI View Article : Google Scholar
5	Kolesnick R and Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:325–328. 1994.PubMed/NCBI View Article : Google Scholar
6	Mielke MM, Bandaru VV, Haughey NJ, Rabins PV, Lyketsos CG and Carlson MC: Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging. 31:17–24. 2010.PubMed/NCBI View Article : Google Scholar
7	Milhas D, Clarke CJ and Hannun YA: Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids. FEBS Lett. 584:1887–1894. 2010.PubMed/NCBI View Article : Google Scholar
8	Khan M, Sekhon BK, Sekhon CS, Singh I and Singh AK: Sphingolipids in rat model of transient focal cerebral ischemia: Implication for stroke injury. J. Neurochem: Jun 28, 2008 (Epub ahead of print).
9	Tu R, Yang W and Hu Z: Inhibition of sphingomyelin synthase 1 affects ceramide accumulation and hydrogen peroxide-induced apoptosis in Neuro-2a cells. Neuroreport. 27:967–973. 2016.PubMed/NCBI View Article : Google Scholar
10	Fikadu Geta T, Philipp T and Holthuis JCM: The multigenic sphingomyelin synthase family. J Biol Chem. 281:29421–29425. 2006.PubMed/NCBI View Article : Google Scholar
11	Qin R, Chen ML, Zhu K, Deng JB and Shi YY: Sphingomyelin synthase 2 deficiency decreases atherosclerosis and inhibits inflammation in mice. Sheng Li Xue Bao. 62:333–338. 2010.PubMed/NCBI(In Chinese).
12	Hailemariam TK, Huan C, Liu J, Li Z, Roman C, Kalbfeisch M, Bui HH, Peake DA, Kuo MS, Cao G, et al: Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation. Arterioscler Thromb Vasc Biol. 28:1519–1526. 2008.PubMed/NCBI View Article : Google Scholar
13	Gowda S, Yeang C, Wadgaonkar S, Anjum F, Grinkina N, Cutaia M, Jiang XC and Wadgaonkar R: Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 300:L430–L440. 2011.PubMed/NCBI View Article : Google Scholar
14	Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989.PubMed/NCBI View Article : Google Scholar
15	Zhang F, Guo RM, Yang M, Wen XH and Shen J: A stable focal cerebral ischemia injury model in adult mice: Assessment using 7T MR imaging. AJNR Am J Neuroradiol. 33:935–939. 2012.PubMed/NCBI View Article : Google Scholar
16	Pérez JM and Pascau J: Image Processing with ImageJ. Packt Publishing, 2016.
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
18	Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM and Woodruff TM: Toll-like receptors in ischemia-reperfusion injury. Shock. 32:4–16. 2009.PubMed/NCBI View Article : Google Scholar
19	Rahimian R, Béland LC and Kriz J: Galectin-3: Mediator of microglia responses in injured brain. Drug Discov Today. 23:375–381. 2018.PubMed/NCBI View Article : Google Scholar
20	Fernandes Bertocchi AP, Campanhole G, Wang PH, Gonçalves GM, Damião MJ, Cenedeze MA, Beraldo FC, Teixeira VP, Reis M, Mazzali M, et al: A role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury. Transpl Int. 21:999–1007. 2008.PubMed/NCBI View Article : Google Scholar
21	Yan YP, Lang BT, Vemuganti R and Dempsey RJ: Galectin-3 mediates post-ischemic tissue remodeling. Brain Res. 1288:116–124. 2009.PubMed/NCBI View Article : Google Scholar
22	Song H, Liu S, Zhao Z, Sun W, Wei X, Ma X, Zhao P and Gao D: Increased cycles of DC/CIK immunotherapy decreases frequency of tregs in patients with resected NSCLC. Int Immunopharmacol. 52:197–202. 2017.PubMed/NCBI View Article : Google Scholar
23	Liu M, Eguchi N, Yamasaki Y, Urade Y, Hattori N and Urabe T: Focal cerebral ischemia/reperfusion injury in mice induces hematopoietic prostaglandin D synthase in microglia and macrophages. Neuroscience. 145:520–529. 2007.PubMed/NCBI View Article : Google Scholar
24	Ohsawa K, Imai Y, Sasaki Y and Kohsaka S: Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem. 88:844–856. 2010.PubMed/NCBI View Article : Google Scholar
25	Yoshinori I and Shinichi KJG: Intracellular signaling in M-CSF-induced microglia activation: Role of Iba1. Glia. 40:164–174. 2002.PubMed/NCBI View Article : Google Scholar
26	Wang M, Uchiumi O, Ogiso H, Shui Y, Zou J, Hashizume C, Taniguchi M, Okazaki T and Kato N: Stressful learning paradigm precludes manifestation of cognitive ability in sphingomyelin synthase-2 knockout mice. Behav Brain Res. 319:25–30. 2017.PubMed/NCBI View Article : Google Scholar
27	Luberto C, Yoo DS, Suidan HS, Bartoli GM and Hannun YA: Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts. J Biol Chem. 275:14760–14766. 2000.PubMed/NCBI View Article : Google Scholar
28	Liu GJ, Middleton RJ, Hatty CR, Kam WWY, Chan R, Pham T, Harrison-Brown M, Dodson E, Veale K and Banati RB: The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol. 24:631–653. 2014.PubMed/NCBI View Article : Google Scholar
29	Vegeto E, Belcredito S, Ghisletti S, Meda C, Etteri S and Maggi A: The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology. 147:2263–2272. 2006.PubMed/NCBI View Article : Google Scholar
30	Moon JB, Lee CH, Park CW, Cho JH, Hwang IK, Yoo KY, Choi JH, Shin HC and Won MH: Neuronal degeneration and microglial activation in the ischemic dentate gyrus of the gerbil. J Vet Med Sci. 71:1381–1386. 2009.PubMed/NCBI View Article : Google Scholar
31	Lambertsen K, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, et al: Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci. 29:1319–1330. 2009.PubMed/NCBI View Article : Google Scholar
32	Wong CH and Crack PJ: Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Curr Med Chem. 15:1–14. 2008.PubMed/NCBI View Article : Google Scholar
33	Kim S, Kim SY, Pribis JP, Lotze M, Mollen KP, Shapiro R, Loughran P, Scott MJ and Billiar TR: Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. Mol Med. 19:88–98. 2013.PubMed/NCBI View Article : Google Scholar
34	Yang QW, Li JC, Lu FL, Wen AQ, Xiang J, Zhang LL, Huang ZY and Wang JZ: Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J Cereb Blood Flow Metab. 28:1588–1596. 2008.PubMed/NCBI View Article : Google Scholar
35	Ma Y, He M and Qiang L: Exercise therapy downregulates the overexpression of TLR4, TLR2, MyD88 and NF-κB after cerebral ischemia in rats. Int J Mol Sci. 14:3718–3733. 2013.PubMed/NCBI View Article : Google Scholar
36	Wullaert A, Bonnet MC and Pasparakis M: NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res. 21:146–158. 2011.PubMed/NCBI View Article : Google Scholar
37	Howard EF, Chen Q, Cheng C, Carroll JE and Hess D: NF-kappa B is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells. Neurosci Lett. 248:199–203. 1998.PubMed/NCBI View Article : Google Scholar
38	Wagner SA, Satpathy S, Beli P and Choudhary CJEJ: SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes. EMBO J. 35:1868–1884. 2016.PubMed/NCBI View Article : Google Scholar